These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38507033)

  • 1. Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model.
    Yalamarty SSK; Filipczak N; Pathrikar T; Cotter C; Ataide JA; Luther E; Paranjape S; Torchilin V
    Drug Deliv Transl Res; 2024 Aug; 14(8):2171-2185. PubMed ID: 38507033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of mAb 2C5-modified dendrimer-based micelles for the co-delivery of siRNA and chemotherapeutic drug in xenograft mice model.
    Yalamarty SSK; Filipczak N; Pathrikar T; Cotter C; Ataide JA; Luther E; Paranjape S; Torchilin V
    Res Sq; 2023 Dec; ():. PubMed ID: 38168301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA.
    Pan J; Attia SA; Subhan MA; Filipczak N; Mendes LP; Li X; Kishan Yalamarty SS; Torchilin VP
    Mol Pharm; 2020 May; 17(5):1638-1647. PubMed ID: 32233497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
    Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
    Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers.
    Yalamarty SSK; Filipczak N; Li X; Pathrikar TV; Cotter C; Torchilin VP
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
    J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy.
    Zhang CG; Zhu WJ; Liu Y; Yuan ZQ; Yang SD; Chen WL; Li JZ; Zhou XF; Liu C; Zhang XN
    Sci Rep; 2016 Mar; 6():23859. PubMed ID: 27030638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.
    Elbayoumi TA; Pabba S; Roby A; Torchilin VP
    J Liposome Res; 2007; 17(1):1-14. PubMed ID: 17454399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
    Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery.
    Zhang X; Pan J; Yao M; Palmerston Mendes L; Sarisozen C; Mao S; Torchilin VP
    Eur J Pharm Biopharm; 2020 Sep; 154():43-49. PubMed ID: 32645383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.
    Xia Y; Xu T; Wang C; Li Y; Lin Z; Zhao M; Zhu B
    Int J Nanomedicine; 2018; 13():143-159. PubMed ID: 29317822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.
    Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M
    AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice.
    Gupta B; Torchilin VP
    Cancer Immunol Immunother; 2007 Aug; 56(8):1215-23. PubMed ID: 17219149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
    Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
    J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy.
    Narayanaswamy R; Torchilin VP
    Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.
    ElBayoumi TA; Torchilin VP
    Clin Cancer Res; 2009 Mar; 15(6):1973-80. PubMed ID: 19276264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo.
    Lu HL; Syu WJ; Nishiyama N; Kataoka K; Lai PS
    J Control Release; 2011 Nov; 155(3):458-64. PubMed ID: 21689700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.